For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Ablation is an advanced treatment option for various diseases such as cancers, cardiac arrhythmias, and other medical conditions. Ultrasonic ablation is a noninvasive procedural technique that uses sound wave and is concentrated at the diseased area of the tissue, leading to heating and cellular destruction of the diseased tissue. Ultrasonic or magnetic resonance imaging (MRI) is performed that directs the ablation device to the diseased tissue. Ultrasonic tissue ablation system is designed. Radiofrequency and ultrasonic ablation devices are considered the most preferred and selected products by doctors and physicians. Ultrasonic ablation is a minimally invasive surgical procedure that involves a local anesthetic and mild sedation. This procedure is primarily used to reduce chronic low-back and neck pain caused due to degeneration of joints (due to arthritis and other spinal conditions).
Scope of the Report:
This report focuses on the Ultrasonic Tissue Ablation System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Ultrasonic Tissue Ablation System is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Ethicon, Inc.
- Johnson & Johnson
- Misonix Inc.
- SonaCare Medical, LLC.
- INSIGHTEC Ltd
- Integra LifeSciences Corporation
- Alpinion Medical Systems Co., Ltd.
- Chongqing Haifu Medical Technology Co., Ltd
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- High-intensity Focused Ultrasonic (HIFU) Ablators
- Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
- Ultrasonic Surgical Ablation Systems
- Shock wave therapy Systems
Market Segment by Applications, can be divided into
- Ambulatory Surgical centers
- Specialty Care Unit
There are 15 Chapters to deeply display the global Ultrasonic Tissue Ablation System market.
Chapter 1, to describe Ultrasonic Tissue Ablation System Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Ultrasonic Tissue Ablation System, with sales, revenue, and price of Ultrasonic Tissue Ablation System, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Ultrasonic Tissue Ablation System, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Ultrasonic Tissue Ablation System market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Ultrasonic Tissue Ablation System sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source